Regenxbio Inc (NASDAQ:RGNX)
| 37.57 BATS BZX Real-Time Price As of 2:23pm ET |  -0.73 / -1.91%Today’s Change | 25.93 Today|||52-Week Range 50.26 | -17.17% Year-to-Date |
Latest RGNX News | Press Releases
No recent news for Regenxbio Inc.
Today’s Trading
| Previous close | 38.30 |
| Today’s open | 38.47 |
| Day’s range | 37.43 - 38.75 |
| Volume | 5,630 |
| Average volume (3 months) | 340,728 |
| Market cap | $1.6B |
Data as of 2:23pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | -15.57% |
| Earnings growth (this year) | -52.88% |
| Earnings growth (next 5 years) | +1.73% |
| Revenue growth (last year) | +338.70% |
| P/E ratio | NM |
| Price/Sales | 10.94 |
| Price/Book | 3.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo Therapeutics... | +0.11 | +0.98% |
| QUREUniqure NV | +0.23 | +0.67% |
| SAVACassava Sciences Inc | -2.20 | -2.74% |
| AUPHAurinia Pharmaceutic... | -0.02 | -0.16% |
Data as of 2:28pm ET, 06/17/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$1.11 |
| Annual revenue (last year) | $154.6M |
| Annual profit (last year) | -$111.3M |
| Net profit margin | -71.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
